Delivery Order SPE2DB22D3301-SPE2DB24FZ1UL

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 2,000 mg vials of the medication SOLU-MEDROL, with a ceiling value of $1,381.68 and a performance period extending to June 18, 2025. The contract is a firm-fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,911.50, is for the delivery of SOLU-MEDROL 1,000 mg vials, a specialty pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $1,066.83, is for the delivery of 2,000 mg SOLU-MEDROL vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 mg vials of the drug SOLU-MEDROL, with a ceiling value of $1,314.45 and a completion date of June 4, 2025. The contract is not set aside and was competed openly. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,089.82 firm fixed-price contract is for the supply of SOLU-MEDROL 125 MG VIALS, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SOLU-MEDROL 1,000 MG VIALS, a pharmaceutical product, with a firm fixed price ceiling value of $3,841.13 and a performance period through June 26, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
The Defense Logistics Agency (DLA) awarded a $1,131.01 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,691,153 SOLU-MEDROL 125 mg vials. This order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp that has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the supply of Solu-Medrol 125 mg vials, a pharmaceutical product. The contract has a ceiling value of $2,630.37 and a completion date of July 18, 2024. It is a firm fixed-price contract type. AmerisourceBergen, a major pharmaceutical distributor, will provide these medical supplies to support military treatment facilities and healthcare...
The provided information details a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of SOLU MEDROL 125MG 25S, a medical product, with a Ceiling Value of $1,354.40 and a firm fixed price. The contract is not set aside and has an Ultimate Completion Date of June 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $5,875.84 firm fixed price contract is for the supply of SOLU-MEDROL 125 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of August 30, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the federal government, holding numerous Indefinite Delivery Contracts (IDCs) with...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ1UL
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 mg vials of the medication Solu-Medrol. The contract has a firm fixed price of $1,850.35 and a completion date of July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities, including pharmaceuticals and medical supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/29/24, 9:19 AM